| Symbol | IMCR |
|---|---|
| Name | IMMUNOCORE HOLDINGS PLC |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 92 PARK DRIVE,MILTON PARK, ABINGDON, OX14 4RY, United Kingdom |
| Telephone | +44 1235438600 |
| Fax | — |
| — | |
| Website | https://www.immunocore.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001671927 |
| Description | Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States. Additional info from NASDAQ: |
Immunocore reports second quarter financial results and provides a business update
Read moreImmunocore to report second quarter 2026 financial results and host call on August 6, 2026
Read moreImmunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
Read moreImmunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
Read moreRatcliffe Peter John 🟢 acquired 27.5K shares (1 derivative) of Immunocore Holdings plc (IMCR) at $28.52 Transaction Date: May 27, 2026 | Filing ID: 000002
Read morePeterson Kristine 🟢 acquired 27.5K shares (1 derivative) of Immunocore Holdings plc (IMCR) at $28.52 Transaction Date: May 27, 2026 | Filing ID: 000002
Read morePao William 🟢 acquired 27.5K shares (1 derivative) of Immunocore Holdings plc (IMCR) at $28.52 Transaction Date: May 27, 2026 | Filing ID: 000002
Read moreKaul Siddharth 🟢 acquired 27.5K shares (1 derivative) of Immunocore Holdings plc (IMCR) at $28.52 Transaction Date: May 27, 2026 | Filing ID: 000002
Read moreHerbst Roy Steven 🟢 acquired 27.5K shares (1 derivative) of Immunocore Holdings plc (IMCR) at $28.52 Transaction Date: May 27, 2026 | Filing ID: 000002
Read moreBell John Irving 🟢 acquired 27.5K shares (1 derivative) of Immunocore Holdings plc (IMCR) at $28.52 Transaction Date: May 27, 2026 | Filing ID: 000002
Read more